- Home
- DNLI vs BELFA Comparison
DNLI vs BELFA Comparison
Compare DNLI & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | BELFA |
|---|---|---|
| Founded | 2013 | 1949 |
| Country | United States | United States |
| Employees | N/A | 4964 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | DNLI | BELFA |
|---|---|---|
| Price | $18.80 | $248.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $34.33 | ★ $174.25 |
| AVG Volume (30 Days) | ★ 1.6M | 43.2K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.74 |
| Revenue Next Year | $408.85 | $6.34 |
| P/E Ratio | ★ N/A | $40.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.58 | $62.78 |
| 52 Week High | $23.77 | $276.21 |
Technical Indicators
Market Signals| Indicator | DNLI | BELFA |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 55.89 |
| Support Level | $18.86 | $209.60 |
| Resistance Level | $20.40 | $276.21 |
| Average True Range (ATR) | 1.01 | 10.93 |
| MACD | -0.03 | -3.11 |
| Stochastic Oscillator | 40.85 | 53.27 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About BELFA Bel Fuse Inc.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.